Episode 14: Can A Blood Test Really Detect 50+ Cancers?

In this episode, we discuss the viral rise of multi-cancer early detection blood tests (MCEDs) that claim to screen for 50+ cancers with a single blood draw and promise peace of mind (i.e. Galleri & Cancerguard). We unpack why these tests are so compelling, what the marketing gets right (and what it leans on), and what it can feel like to navigate these conversations as patients and as primary care doctors. We also tease the key questions we think matter most—who might consider them, what happens after a “signal detected” result, and why this isn’t a simple yes/no situation in real life. 00:00 Podcast mission01:13 Why this topic now04:43 What these tests promise05:50 Why it went viral08:36 Marketing tactics12:19 Cost and access14:05 How the test works18:01 Scary stats vs evidence19:45 Does it detect cancer21:04 Sensitivity specificity explained23:32 Predictive value reality check25:55 Explaining False Positives26:41 Why It Cannot Replace Screening28:12 Pathfinder Study Setup31:24 Pathfinder Results Breakdown32:40 Workup Cascade And Harms36:00 Insurance And Downstream Costs37:23 NHS Trial Early Signals40:55 Guidelines And Shared Decisions44:15 When Doctors Might Use It49:23 Final Takeaways And Wrap50:01 Podcast Medical Disclaimer📖 Read the full episode summary, sources, and resources on our Substack: 👉www.theantisocialdoctors.com